Description

Femoston (estradiol) Coated Tablets 1 mg/10 mg. №28

Ingredients:

Each coated tablet contains 1 mg of estradiol and 10 mg of dydrogesterone.

Dosage:

The usual dose is one tablet daily, preferably at the same time each day.

Indications:

Femoston tablets are indicated for hormone replacement therapy in postmenopausal women with an intact uterus.

Contraindications:

Do not use Femoston if you have a history of hormone-sensitive cancers, liver disease, or undiagnosed vaginal bleeding.

Directions:

Swallow the tablet whole with water. Follow the instructions provided by your healthcare provider.

Scientific Evidence:

Estradiol and dydrogesterone in Femoston have been extensively studied for their efficacy in managing menopausal symptoms and preventing osteoporosis. Research published in the Journal of Menopause demonstrated that estradiol therapy significantly improved vasomotor symptoms and quality of life in postmenopausal women.

Additional Information:

It is essential to discuss the risks and benefits of hormone replacement therapy with your healthcare provider before starting Femoston. Regular monitoring is crucial to ensure the therapy’s safety and effectiveness.

Studies have shown that Femoston offers a well-tolerated and effective option for managing menopausal symptoms, with a lower risk of endometrial hyperplasia compared to estrogen-alone therapy. Consult your doctor for personalized advice on hormone replacement therapy.